Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Carmustine (solution for intratumoral injection)

EU orphan designation number: EU/3/02/085
Active ingredient: Carmustine (solution for intratumoral injection)
Indication: Treatment of glioma
Sponsor: Icon Clinical Research UK Ltd
2 Globeside, Globeside Business Park, Marlow, Buckinghamshire SL7 1TB, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
07/03/2002 Centralised Orphan - Designation EMEA/OD/067/01 (2002)959 of 05/03/2002
03/06/2003 Other procedure EMEA/OD/067/01
30/04/2012 Centralised Orphan - Removal of orphan designation from Community Register